NEMO Therapeutics was founded to improve the quality of life and functional outcome for people suffering with neurological conditions, with an initial focus on Autism. With over 80 man-years experience in deep diving, hyperbaric oxygen therapy, and clinical wound care - we recognised that it was possible to create a new system of care which would allow the non-invasive treatment of neuro-inflammatory conditions in the home or care facility.
NEMO stands for Neurological Enhancement through Managed-dose Oxygen. By thinking differently we have created a new patented process for hyperoxic therapy which we have validated in multiple pilot studies with teens and pre-teens moderately to severely affected by autism. These studies yielded remarkable and seemingly permanent results.
Our approach applies to multiple other conditions such as cerebral palsy, Alzheimer's disease / dementia, mild traumatic brain injury, persistent symptoms of post concussion and stroke.